Using the eosin‐5‐maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis

Authors:

Abstract
Background: Flow cytometric analysis of eosin‐5‐maleimide (EMA)‐labeled red blood cells (RBCs) has been used as a screening test for the diagnosis of patients with hereditary spherocytosis (HS). We assessed the fluorescence profiles for patients having HS and hereditary pyropoikilocytosis (HPP) together with their red cell indices.Methods: Flow cytometry was used to analyze EMA‐labeled RBCs. Membrane protein defects and spectrin variants were identified by SDS‐polyacrylamide gel electrophoresis.Results: An overlay of single fluorescence peaks for normal individuals, and those with HS and HPP revealed a graded fluorescence intensity (normal > HS > HPP). The area under each peak defined a specific RBC subpopulation; namely, normal RBCs, spherocytes, and microspherocytes. HS RBCs having a gross reduction in band 3 or spectrin content gave fluorescence readings almost as low as those for HPP. Complex fluorescence profiles were obtained for isolated HS and HPP cases.Conclusions: The mean cell volume is a useful discriminator for HS and HPP. We presented evidence that a mixed RBC population could occur in some HS and HPP patients, either in a transient manner or for a long‐term period. A differential diagnostic scheme for detecting HPP and HS by flow cytometry is proposed. © 2008 Clinical Cytometry Society

This publication has 19 references indexed in Scilit: